So why don't you give us an introduction first to partnerships objectively in diagnostics and early stage diagnostics and how that typically works, and then we can go into the sort of the benefits and, and the challenges that we're seeing in the industry around this topic.

You know, again, I think it's a great topic, very interesting topic.

People think of partnerships, as you said, as, as dilution or selling the business and whatnot.

And I think that has to be reframed along the lines of what I'd say synergy, right? And, and I think if you have the mindset of synergy and looking for synergies, I think that's a fundamental start.

You know, especially when I work with smaller companies and founder-led companies, they've spent their own thirty years in regards to novel biology and chemistry and developing biomarkers for unique signatures.

And again, that's fantastic, right? That's what changes the world.

That's how we change healthcare and impact to patients, et cetera.

Mm.